Boost For India’s Generic Pharma Majors
Biocon, Dr Reddy’s and Mankind Pharma stress on development and manufacturing of biological drugs, look to cash in on a growing market.
pharmaceutical
October 2024
August 2024
January 2024
December 2023
November 2023
September 2023
August 2023
Lupin shares touch 52-week high as Q1 profit surges 77%
Lupin deals in branded and generic formulations, active pharmaceutical ingredients (APIs), and biosimilars.
Sun Pharma shares hit 52-week high on acquiring Israeli company
As per the regulatory filing by the pharmaceutical major, through the acquisition, Sun Pharma aims to facilitate the consolidation of business in Israel.
Akums Drugs and Pharmaceuticals Limited: Endeavour to deliver Quality Medicines and Advancing Pharmaceutical Manufacturing
Established with a clear vision, Akums remains unwavering in its commitment to excel in the pharmaceutical industry.
Lupin shares hit 52-week high on strong Q2 results
The company's revenue from operations in the Q2 of FY24, stood at ₹5,038.6 crore, up 21.5% YoY as against ₹4,145.5 crore in the same period last year.
Lupin acquires five brands from Italy's Menarini to strengthen therapy portfolio
The brands are Piclin (Picosulphate Sodium), Menoctyl (Otilonium Bromide), Sucramal O (Sucralfate + Oxetacaine), Pyridium (Phenazopyridine) and Distaclor (Cefaclor), the company says.
Glenmark Pharma slides 6% on deal to sell drug business to Nirma
Glenmark Pharma entered into a definitive agreement with Nirma Limited to divest a 75% stake in Glenmark Life Sciences at a price of ₹615/- per share for an aggregate consideration of ₹5,615 crore.
Vicky Ramancha looking ahead to a successful 2024 for RNR Healthcare
Vicky Ramancha states that healthcare as a business is in a significant growth stage and RNR Healthcare is looking to double its revenues and profitability in the next 2 years
New scheme for R&D in pharma, medtech
Nine established pharma companies will be selected on the basis of their willingness to carry out research in six priority areas with academic collaboration in government research institutions.
Sun Pharma profit declines 2% to ₹2,022.5 cr; revenue up 11% in Q1
The revenue from operations of the Mumbai-based company stood at ₹11,940.8 crore, up 10.9% as against 10,761.7 crore in the Q1 of FY23.
